BCL6high and/or BACH2low expression is associated with IKZF1 deletion, BCR/ABL1 fusion, leukemic cell proliferation, and inferior outcomes in B-ALL. Here, ABL1 is linked to precursor B-cell acute lymphoblastic leukemia.